Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP), a developer of oral drug delivery systems, today announced that it has entered into definitive agreements with investors to purchase an aggregate of 1,580,000 shares of common stock at a price of $10.00 per share in a registered direct offering….
Oramed Pharmaceuticals to purchase $15,800,000 shares in registered direct offering
No comments:
Post a Comment